[{"AccountsPayableCurrent_0_Q1_USD":29703000.0,"CommonStockNoParValue_0_Q1_USD":0.0,"InterestExpenseDebt_1_Q1_USD":5561000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-172243000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":20750000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":6907000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":2860000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":2607000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":282833000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":36.95,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":119446000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":88838.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":24563.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":16.47,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":5315110.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":106407000.0,"NonoperatingIncomeExpense_1_Q1_USD":-21299000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":2895000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":2895000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":2895000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":2895000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0_Q1_USD":27507000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":650000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":424000.0,"PrepaidRent_0_Q1_USD":2850000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":121958000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2607000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q1_USD":25.41,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1151000.0,"RestrictedCash_0_Q1_USD":1000000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":340000.0,"PaymentsForTenantImprovements_1_Q1_USD":1600000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-476000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":37000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-20000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":2172000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":5781000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":241000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":111512000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":16879000.0,"EquityMethodInvestments_0_Q1_USD":3958000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q1_USD":119446000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":105000.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":650000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":9462000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":16879000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":41259000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":1000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":429239000.0,"OtherAssetsCurrent_0_Q1_USD":4782000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-1380000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q1_shares":9136829.0,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent_0_Q1_USD":15625000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":45.63,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":25.41,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1016000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-150722000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-23366000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":285600000.0,"LiabilitiesCurrent_0_Q1_USD":122098000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":532669000.0,"Liabilities_0_Q1_USD":410711000.0,"InventoryNet_0_Q1_USD":4582000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":25733000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":4337000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":14475000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":694000.0,"GrossProfit_1_Q1_USD":727000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.07,"CommonStockValue_0_Q1_USD":1175139000.0,"CommonStockSharesOutstanding_0_Q1_shares":58387948.0,"CommonStockSharesIssued_0_Q1_shares":58387948.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":428239000.0,"AssetsCurrent_0_Q1_USD":474446000.0,"Assets_0_Q1_USD":532669000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":9727197.0,"AdditionalPaidInCapital_0_Q1_USD":92129000.0,"AccountsReceivableNetCurrent_0_Q1_USD":4337000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":37288000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":7.44,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":283333000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":8933000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":9136829.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-152000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":41259000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1_Q1_USD":42821000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":17864000.0,"OtherAssets_0_Q1_USD":4073000.0,"InventoryWorkInProcess_0_Q1_USD":4287000.0,"InventoryRawMaterials_0_Q1_USD":0.0,"InventoryFinishedGoods_0_Q1_USD":295000.0,"IncreaseDecreaseInInventories_1_Q1_USD":3609000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":350461.0,"ShareBasedCompensation_1_Q1_USD":16879000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":95601000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":56070000.0,"OperatingIncomeLoss_1_Q1_USD":-150944000.0,"OperatingExpenses_1_Q1_USD":151671000.0,"InterestPaidNet_1_Q1_USD":0.0,"IncomeTaxesPaidNet_1_Q1_USD":0.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":76770000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":56412439.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1145310000.0,"ProfitLoss_1_Q1_USD":-172937000.0,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_0_Q1_USD":136404000.0,"Ticker":"BHVN","CIK":"1689813","name":"BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.","OfficialName":"Biohaven Pharmaceutical Holding Company Ltd. Common Shares","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7425158774.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200507"}]